Tur, Experimental Pathology and Immunotherapy, Institute for Pathology, University Hospital Giessen and Marburg, Germany, andī) Dr Peter Duncan, Afrobodies, South Africa. Novel methods for selection of antibodies are developed in close collaboration with:Ī) Dr Mehmet K. The main characteristics of these novel agents are: The major aim of our research is the use of medical biotechnology methods including antibody technologies, protein engineering and expression, to develop and evaluate knowledge-based innovative recombinant immunodiagnostics and therapeutics. Tier 1 South African Research Chair in Cancer Biotechnology Division of Chemical & Systems Biology Department of Integrative Biomedical Sciences Member Member and Executive Director, Medical Biotechnology and Immunotherapy Unit Faculty of Health Sciences. Selected publications | Contact details | Group members | Collaborations
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |